ConductScience.org, home

Paper11288872

Towards a better understanding of the cisplatin mode of action.

Marchán V and 3 others. Chemistry, 2001. Cited by 35 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Towards a better understanding of the cisplatin mode of action. Papers, record 11288872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11288872

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Towards a better understanding of the cisplatin mode of action.
PubMed
Journal
Chemistry
PubMed
Year
2001
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
1.1
iCite
Revised in PubMed
2019-09-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marchán VV
2Moreno VV
3Pedroso EE
4Grandas AA

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
Chromatography, High Pressure Liquid
DNA
Peptides
Spectrum Analysis

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
40099677Protonation of Pt(IV) Anticancer Complexes Assayed by Vibrational Ion Spectroscopy.Chempluschem2025https://conductscience.org/library/papers/40099677PubMed
37936720Alginate-based hydrogel platform embedding silver nanoparticles and cisplatin: characterization of the synergistic effect on a breast cancer cell line.Front Mol Biosci2023https://conductscience.org/library/papers/37936720PubMed
34214537Metallodrug-protein interaction probed by synchrotron terahertz and neutron scattering spectroscopy.Biophys J2021https://conductscience.org/library/papers/34214537PubMed
33448132On the Heterogeneous Nature of Cisplatin-1-Methyluracil Complexes: Coexistence of Different Aggregation Modes and Partial Loss of NH3 Ligands as Likely Explanation.ChemistryOpen2021https://conductscience.org/library/papers/33448132PubMed
27891174Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro.Chin Med2016https://conductscience.org/library/papers/27891174PubMed
19200747The influence of Cisplatin on the gas-phase dissociation of oligonucleotides studied by electrospray ionization tandem mass spectrometry.J Am Soc Mass Spectrom2009https://conductscience.org/library/papers/19200747PubMed
19052781Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.J Biol Inorg Chem2009https://conductscience.org/library/papers/19052781PubMed
17534671Incorporation of two modified nucleosides allows selective platination of an oligonucleotide making it suitable for duplex cross-linking.J Biol Inorg Chem2007https://conductscience.org/library/papers/17534671PubMed
12774240Resistance mechanisms of gastrointestinal cancers: why does conventional chemotherapy fail?Int J Colorectal Dis2003https://conductscience.org/library/papers/12774240PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11288872

GET https://conductscience.org/api/papers/v1/11288872/authors